Mukherjee, A.G.; Wanjari, U.R.; Gopalakrishnan, A.V.; Kannampuzha, S.; Murali, R.; Namachivayam, A.; Ganesan, R.; Renu, K.; Dey, A.; Vellingiri, B.;
et al. Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510. Vaccines 2024, 12, 996.
https://doi.org/10.3390/vaccines12090996
AMA Style
Mukherjee AG, Wanjari UR, Gopalakrishnan AV, Kannampuzha S, Murali R, Namachivayam A, Ganesan R, Renu K, Dey A, Vellingiri B,
et al. Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510. Vaccines. 2024; 12(9):996.
https://doi.org/10.3390/vaccines12090996
Chicago/Turabian Style
Mukherjee, Anirban Goutam, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri,
and et al. 2024. "Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510" Vaccines 12, no. 9: 996.
https://doi.org/10.3390/vaccines12090996
APA Style
Mukherjee, A. G., Wanjari, U. R., Gopalakrishnan, A. V., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Renu, K., Dey, A., Vellingiri, B., & Prabakaran, D. S.
(2024). Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510. Vaccines, 12(9), 996.
https://doi.org/10.3390/vaccines12090996
